According to a new report Asia-Pacific Molecular Diagnostics Market, published by KBV Research, the Asia-Pacific Molecular Diagnostics Market is expected to register a CAGR of 11.4% during the forecast period (2016 - 2022). The China market dominated the Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country in 2015, and would continue to be a dominant market till 2022 growing at a CAGR of 8.8 % during the forecast period. The Japan market is expected to witness a CAGR of 7.4% during (2016 - 2022).
Additionally, The India market is expected to witness a CAGR of 11.3% during (2016 - 2022). The Polymerase Chain Reaction market dominated the Asia-Pacific Molecular Diagnostics Market by Technology in 2015, and would continue to be a dominant market till 2022. The Other Technologies market is expected to witness a CAGR of 13.4% during (2016 - 2022). The Isothermal Nucleic Acid Amplification Technology market is expected to witness a CAGR of 11.9% during (2016 - 2022).
The Infectious Diseases market dominated the Asia-Pacific Molecular Diagnostics Market by Application in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $1,220.4 million by 2022. The Other Applications market is expected to witness a CAGR of 15.2% during (2016 - 2022). The Oncology market is expected to witness a CAGR of 11.9% during (2016 - 2022). The Hospital & Academic Laboratories market dominated the China Molecular Diagnostics Market by End User in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 8.8 % during the forecast period.
The Reference Laboratories market is expected to witness a CAGR of 12.9% during (2016 - 2022). Additionally, The Other End Users market is expected to witness a CAGR of 14.1% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Asia-PacificMolecular Diagnostics have been discussed in the report along with the elaborated company profiles of Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
Full report : https://www.kbvresearch.com/asia-pacific-molecular-diagnostics-market/
Research Scope
Global Molecular Diagnostics Market
North America Molecular Diagnostics Market
Unique Offerings 
